Acadia Healthcare Company, Inc. (ACHC): Results of Operations and Financial Condition
Acadia Healthcare Company, Inc. (ACHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_994474.htm EXHIBIT 99.1 ex_994474.htm Exhibit 99.1 ACADIA HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS AND UPDATES FULL YEAR 2026 FINANCIAL AND CASH FLOW GUIDANCE FRANKLIN, Tenn. (July 28, 2026 ) – Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASD
How this was made
The 30-second read
Why it matters
Traders should focus on the direction of updated full-year guidance and whether the company expects cash flow to remain resilient despite lower adjusted EBITDA and adjusted EPS versus the prior year.
Market read
Q2 shows flat top-line growth but materially lower earnings and adjusted EBITDA year over year, while operating cash flow improved and capex fell, setting up estimate and guidance-driven repricing.
What to watch
Same-facility revenue per patient day declined 0.8% due to supplemental payment timing; investors may overreact to headline EPS without normalizing for these program effects.
Background
The 8-K includes Item 2.02 results and an Exhibit 99.1 press release with Q2 2026 financials and commentary, plus an update to full-year 2026 guidance.
Ticker impact
Acadia reported Q2 2026 revenue of $865.8M, net income $10.9M, and updated full-year 2026 financial and cash flow guidance in an 8-K.
Near-term volatility likely, with focus on whether updated full-year guidance offsets the year-over-year earnings decline.
The filing provides detailed quarterly datapoints (revenue flat, adjusted EBITDA down, operating cash flow up, capex down) that can drive estimate revisions, but the excerpt does not include the specific updated guidance numbers.
Market effects
Behavioral healthcare operators may see read-across on reimbursement timing effects (supplemental payment programs) and reserve adjustments impacting earnings quality.
Supplemental payment program timing in Florida and Tennessee is highlighted, which can matter for other providers with similar state mix.
Limited, as this is company-specific US healthcare earnings and guidance.
Counterpoint
The reported earnings drop may be partly driven by timing and reserve adjustments, while operating cash flow strength and capex reduction could indicate improving cash generation despite lower accrual earnings.
Key entities
- companyAcadia Healthcare Company, Inc.
Behavioral healthcare provider reporting Q2 2026 results and updating full-year 2026 financial and cash flow guidance.
- executiveDebbie Osteen
CEO quoted in the release describing operational progress and free cash flow generation.
